Am J Perinatol 2016; 33(08): 732-737
DOI: 10.1055/s-0036-1571327
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Treatment Utility of Postpartum Antibiotics in Chorioamnionitis Study

Anthony L. Shanks
1   Department of Obstetrics and Gynecology, Washington University in St. Louis, St. Louis, Missouri
,
Suwan Mehra
2   Department of Obstetrics and Gynecology, Saint Louis University, Saint Louis, Missouri
,
Gil Gross
2   Department of Obstetrics and Gynecology, Saint Louis University, Saint Louis, Missouri
,
Ryan Colvin
1   Department of Obstetrics and Gynecology, Washington University in St. Louis, St. Louis, Missouri
,
Lorie M. Harper
3   Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama
,
Methodius G. Tuuli
1   Department of Obstetrics and Gynecology, Washington University in St. Louis, St. Louis, Missouri
› Author Affiliations
Further Information

Publication History

07 October 2015

09 December 2015

Publication Date:
18 February 2016 (online)

Abstract

Objective To determine if postpartum antibiotics are necessary for patients with chorioamnionitis after a cesarean delivery (CD).

Study Design Multicenter randomized controlled trial. Laboring patients with singleton gestations and chorioamnionitis who underwent CD were eligible. Patients were treated with ampicillin and gentamicin per standard protocol, then given clindamycin prior to skin incision. Patients were randomized to either postpartum antibiotic prophylaxis or no treatment following delivery. The primary outcome was the rate of endometritis. Assuming a 30% risk of endometritis in patients with chorioamnionitis who undergo CD, 119 patients per arm would be required to detect a 50% decrease in endometritis.

Results The trial was stopped for futility following a planned interim analysis after 80 patients were randomized. There was no difference in the rate of the primary outcome between the two groups (9.8 vs. 7.7%, relative risk [RR]: 1.27; 95% confidence interval [CI]: 0.30, 5.31). A meta-analysis comparing post-CD antibiotics versus no treatment did not find a statistically significant difference between the groups (16.7 vs. 12.0%, pooled RR: 1.43; 95% CI: 0.72, 2.84).

Conclusion Additional postpartum antibiotics do not decrease the rate of endometritis in patients with chorioamnionitis who undergo CD. The current preoperative antibiotic regimen including clindamycin should remain the standard of care in these patients.

This article was presented as an Oral Presentation at Society for Maternal-Fetal Medicine Annual held in San Diego, CA, in February 2015.


 
  • References

  • 1 Gibbs RS, Dinsmoor MJ, Newton ER, Ramamurthy RS. A randomized trial of intrapartum versus immediate postpartum treatment of women with intra-amniotic infection. Obstet Gynecol 1988; 72 (6) 823-828
  • 2 Sperling RS, Ramamurthy RS, Gibbs RS. A comparison of intrapartum versus immediate postpartum treatment of intra-amniotic infection. Obstet Gynecol 1987; 70 (6) 861-865
  • 3 Gilstrap III LC, Leveno KJ, Cox SM, Burris JS, Mashburn M, Rosenfeld CR. Intrapartum treatment of acute chorioamnionitis: impact on neonatal sepsis. Am J Obstet Gynecol 1988; 159 (3) 579-583
  • 4 Edwards RK, Duff P. Single additional dose postpartum therapy for women with chorioamnionitis. Obstet Gynecol 2003; 102 (5, Pt 1) 957-961
  • 5 Chapman SJ, Owen J. Randomized trial of single-dose versus multiple-dose cefotetan for the postpartum treatment of intrapartum chorioamnionitis. Am J Obstet Gynecol 1997; 177 (4) 831-834
  • 6 Turnquest MA, How HY, Cook CR , et al. Chorioamnionitis: is continuation of antibiotic therapy necessary after cesarean section?. Am J Obstet Gynecol 1998; 179 (5) 1261-1266
  • 7 Mackeen AD, Packard RE, Ota E, Speer L. Antibiotic regimens for postpartum endometritis. Cochrane Database Syst Rev 2015; 2: CD001067
  • 8 Mackeen AD, Packard RE, Ota E, Berghella V, Baxter JK. Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery. Cochrane Database Syst Rev 2014; 12: CD009516
  • 9 Smieja M. Current indications for the use of clindamycin: a critical review. Can J Infect Dis Med Microbiol 1998; 9 (1) 22-28
  • 10 Bacchetti P, Deeks SG, McCune JM. Breaking free of sample size dogma to perform innovative translational research. Sci Transl Med 2011; 3 (87) 87ps24